Dr. Ottavia Prunas is an infectious disease modeler dedicated to assessing the real-world impact of public health interventions. Her research focuses on developing and applying advanced statistical tools to tackle complex public health challenges, providing data-driven insights to inform policy and decision-making.
Selected Publications
Prunas, O., Shioda, K., Toscano, C. M., Bastias, M., Valenzuela-Bravo, M. T., Tito, J. D., Warren, J. L., Weinberger, D. M., & De Oliveira, L. H. (2024). Estimated Population-Level Impact of Pneumococcal Conjugate Vaccines Against All-Cause Pneumonia Mortality Among Unvaccinated in 5 Latin American Countries. Journal of Infectious Diseases, 230(4), e768–e776. https://doi.org/10.1093/infdis/jiae144
Prunas, O., Shioda, K., Toscano, C. M., Bastias, M., Valenzuela-Bravo, M. T., Tito, J. D., Warren, J. L., Weinberger, D. M., & De Oliveira, L. H. (2024). Estimated Population-Level Impact of Pneumococcal Conjugate Vaccines Against All-Cause Pneumonia Mortality Among Unvaccinated in 5 Latin American Countries. Journal of Infectious Diseases, 230(4), e768–e776. https://doi.org/10.1093/infdis/jiae144
Prunas, O., Willemsen, J. E., Bont, L., Pitzer, V. E., Warren, J. L., & Weinberger, D. M. (2024). Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology, 35(1), 103–112. https://doi.org/10.1097/EDE.0000000000001680
Prunas, O., Willemsen, J. E., Bont, L., Pitzer, V. E., Warren, J. L., & Weinberger, D. M. (2024). Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology, 35(1), 103–112. https://doi.org/10.1097/EDE.0000000000001680
Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2023). Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel. Clinical Infectious Diseases, 76(1), 113–118. https://doi.org/10.1093/cid/ciac315
Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2023). Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel. Clinical Infectious Diseases, 76(1), 113–118. https://doi.org/10.1093/cid/ciac315
Prunas, O., Warren, J. L., Crawford, F. W., Gazit, S., Patalon, T., Weinberger, D. M., & Pitzer, V. E. (2022). Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science, 375(6585), 1151–1154. https://doi.org/10.1126/science.abl4292
Prunas, O., Warren, J. L., Crawford, F. W., Gazit, S., Patalon, T., Weinberger, D. M., & Pitzer, V. E. (2022). Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science, 375(6585), 1151–1154. https://doi.org/10.1126/science.abl4292